XBiotech
XBIT
65 hedge funds and large institutions have $58.9M invested in XBiotech in 2020 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 23 increasing their positions, 16 reducing their positions, and 14 closing their positions.
44% more repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 16
36% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 14
26% more capital invested
Capital invested by funds: $46.6M → $58.9M (+$12.3M)
8% more funds holding
Funds holding: 60 → 65 (+5)
0.32% less ownership
Funds ownership: 15.21% → 14.89% (-0.32%)
73% less call options, than puts
Call options by funds: $684K | Put options by funds: $2.58M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.44M |
| 2 |
Northern Trust
Chicago,
Illinois
|
+$876K |
| 3 |
QI
QS Investors
New York
|
+$840K |
| 4 |
Wells Fargo
San Francisco,
California
|
+$625K |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
+$478K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
-$3.77M |
| 2 |
Goldman Sachs
New York
|
-$1.27M |
| 3 |
Balyasny Asset Management
Chicago,
Illinois
|
-$536K |
| 4 |
Jane Street
New York
|
-$375K |
| 5 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
-$364K |
XBIT Hedge Fund Activity: Q2 2020 in Review
65 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in XBiotech (XBIT) for Q2 2020, worth a combined $58.9M — up 26% from $46.6M a quarter earlier.
Buyers outnumbered sellers: 19 funds opened new XBIT positions and 14 closed out — a net gain of 5 holders — while 23 added to existing stakes and 16 trimmed.
The largest buyer was Vanguard Group, adding an estimated $2.44M. The largest seller was Bank of America, cutting an estimated $3.77M.
- 65 institutional investors held XBiotech (XBIT) as of Q2 2020, up from 60 in Q1 2020.
- Funds reported $58.9M of XBiotech stock for Q2 2020, up 26% quarter-over-quarter.
- 19 funds opened new XBiotech positions in Q2 2020 and 14 closed out, a net change of +5 holders.
- The largest XBiotech buyer in Q2 2020 was Vanguard Group, an estimated $2.44M added.
- The largest XBiotech seller in Q2 2020 was Bank of America, an estimated $3.77M sold.
Based on aggregated 13F filings for Q2 2020.